Table 4.
Linear | Log | Logistic | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||
|
|
ASE1 | p |
|
ASE1 | p |
|
ASE1 | p | ||||
Intercept | 32.95 | 0.5 | < 0.01 | 3.57 | 0.02 | 0.8 | 2.42 | 0.08 | < 0.01 | ||||
Year-2005 | −1.02 | 0.05 | < 0.01 | −0.04 | < 0.01 | < 0.01 | −0.16 | 0.01 | < 0.01 | ||||
Age-50 (Years) | −0.2 | 0.01 | < 0.01 | −0.01 | < 0.01 | < 0.01 | −0.04 | < 0.01 | < 0.01 | ||||
Sodium-130 (mmol/l) | 0.47 | 0.02 | < 0.01 | 0.02 | < 0.01 | < 0.01 | 0.08 | < 0.01 | < 0.01 | ||||
MELD Score-6 | −0.89 | 0.02 | < 0.01 | −0.05 | < 0.01 | < 0.01 | −0.16 | < 0.01 | < 0.01 | ||||
| |||||||||||||
UNOS Region | Reference Group: 5 | ||||||||||||
1 | −1.52 | 0.49 | < 0.01 | −0.06 | 0.02 | < 0.01 | −0.27 | 0.07 | < 0.01 | ||||
2 | −1.35 | 0.38 | < 0.01 | −0.06 | 0.01 | < 0.01 | −0.22 | 0.06 | < 0.01 | ||||
3 | −3.26 | 0.43 | < 0.01 | −0.11 | 0.02 | < 0.01 | −0.49 | 0.07 | < 0.01 | ||||
4 | 0.23 | 0.34 | 0.5 | 0.02 | 0.01 | 0.09 | 0.04 | 0.06 | 0.46 | ||||
6 | −0.97 | 0.54 | 0.07 | < 0.01 | 0.02 | 0.95 | −0.12 | 0.09 | 0.21 | ||||
7 | −0.59 | 0.42 | 0.16 | −0.02 | 0.02 | 0.32 | −0.1 | 0.07 | 0.14 | ||||
8 | −0.9 | 0.42 | 0.03 | < 0.01 | 0.02 | 0.94 | −0.13 | 0.07 | 0.06 | ||||
9 | −1.41 | 0.36 | < 0.01 | −0.07 | 0.01 | < 0.01 | −0.21 | 0.06 | < 0.01 | ||||
10 | −2.24 | 0.48 | < 0.01 | −0.09 | 0.02 | < 0.01 | −0.39 | 0.07 | < 0.01 | ||||
11 | −2.75 | 0.44 | < 0.01 | −0.1 | 0.02 | < 0.01 | −0.44 | 0.07 | < 0.01 | ||||
| |||||||||||||
Gender | Reference Group: Male | ||||||||||||
Female | 0.49 | 0.22 | 0.02 | < 0.01 | 0.01 | 0.95 | 0.06 | 0.03 | 0.1 | ||||
| |||||||||||||
Race | Reference Group: White | ||||||||||||
Black | 0.34 | 0.41 | 0.41 | 0.02 | 0.02 | 0.23 | 0.06 | 0.06 | 0.31 | ||||
Hispanic | 0.23 | 0.27 | 0.4 | 0.01 | 0.01 | 0.21 | 0.04 | 0.05 | 0.33 | ||||
Asian | 1.76 | 0.55 | < 0.01 | 0.05 | 0.02 | 0.01 | 0.33 | 0.11 | < 0.01 | ||||
Others | −0.57 | 0.89 | 0.52 | −0.01 | 0.04 | 0.74 | −0.11 | 0.15 | 0.48 | ||||
| |||||||||||||
Blood Type | Reference Group: O | ||||||||||||
A | −0.08 | 0.21 | 0.72 | −0.01 | 0.01 | 0.26 | −0.02 | 0.03 | 0.63 | ||||
B | −0.02 | 0.36 | 0.95 | −0.01 | 0.01 | 0.59 | < 0.01 | 0.06 | 0.97 | ||||
AB | −0.59 | 0.78 | 0.44 | −0.05 | 0.03 | 0.08 | −0.19 | 0.11 | 0.1 | ||||
| |||||||||||||
Diagnosis | Reference Group: No or Yes | ||||||||||||
Hepatitis C | −1.33 | 0.33 | < 0.01 | −0.04 | 0.01 | < 0.01 | −0.26 | 0.05 | < 0.01 | ||||
Noncholestatic | 0.76 | 0.33 | 0.02 | 0.06 | 0.01 | < 0.01 | 0.12 | 0.05 | 0.02 | ||||
Cholestatic | −1.26 | 0.45 | 0.01 | −0.05 | 0.02 | < 0.01 | −0.28 | 0.07 | < 0.01 | ||||
Acute Hepatic Necrosis | 2.27 | 0.81 | 0.01 | 0.06 | 0.03 | 0.04 | 0.56 | 0.18 | < 0.01 | ||||
Metastatic Disease | −2.95 | 0.66 | < 0.01 | −0.11 | 0.03 | < 0.01 | −0.53 | 0.11 | < 0.01 | ||||
Malignant Neoplasm | −7.24 | 0.37 | < 0.01 | −0.43 | 0.02 | < 0.01 | −1.23 | 0.06 | < 0.01 | ||||
| |||||||||||||
BMI | Reference Group: (20, 25] | ||||||||||||
(0, 20] | −2.05 | 0.47 | < 0.01 | −0.07 | 0.02 | < 0.01 | −0.28 | 0.07 | < 0.01 | ||||
(25, 30] | 0.02 | 0.27 | 0.95 | 0.01 | 0.01 | 0.25 | −0.01 | 0.04 | 0.8 | ||||
> 30 | −0.09 | 0.27 | 0.74 | < 0.01 | 0.01 | 0.98 | −0.02 | 0.04 | 0.57 | ||||
| |||||||||||||
Hospitalized | Reference Group: Not Hospitalized | ||||||||||||
ICU | −1.83 | 0.65 | < 0.01 | −0.54 | 0.08 | < 0.01 | −0.82 | 0.14 | < 0.01 | ||||
not ICU | −2.41 | 0.42 | < 0.01 | −0.33 | 0.04 | < 0.01 | −0.49 | 0.08 | < 0.01 | ||||
| |||||||||||||
Dialysis | Reference Group: No or Yes | ||||||||||||
Yes | 1.69 | 0.54 | < 0.01 | 0.13 | 0.04 | < 0.01 | 0.49 | 0.09 | < 0.01 |
An offset of L = 36 months is applied for log link.